NASDAQ:

ASTX:

astex™
  • About
  • Pipeline
  • Technology
  • Partners
  • Investors
  • Contact
  • Mission & Values
  • Leadership Team
  • Careers
  • Products
  • Clinical Trials
  • Events
  • Pyramid Platform
  • Corporate Partnerships
  • Intellectual Property
  • Events Calendar
  • Stock Information
  • Corporate Governance
  • Board Committees
  • SEC Filings
  • Press Releases
  • Investor FAQs
  • Annual Reports
  • Investor Kit
  • Email Alerts
  • in the news
  • upcoming events
  • 8-10 March 2012

    International Congress on Targeted...

  • 13-14 March 2012

    Discovery Chemistry Congress 2012

see all the latest events →

product pipeline

AT13387

— in phase 2 clinical trial

SGI-110

— in phase 1 clinical trial

DACOGEN® (AML)

— in phase 3 clinical trial

AT7519

— in phase 2 clinical trial
see all pipeline products →

receive investor updates

Get automatic financial updates and information from NASDAQ.

sign up for email alerts →

Corporate Partnerships

©2011 Astex Pharmaceuticals. All rights reserved.

  • Forward-Looking Statement
  • Site Map
  • Privacy Policy
  • Terms of Use

Astex Pharmaceuticals, Inc.™

4140 Dublin Blvd., Suite 200, Dublin, CA 94568, USA